
# ğŸ“ Note Taking: 2025-06-25

## ğŸ“Œ Clinical Sales
**Main Points**
- Tier2/Tier3 í™•ì¥ì„ ìœ„í•œ Capability í•„ìš”
- Medtronicì˜ ëŒ€ê·œëª¨ ìœ í†µì‚¬ í™œë™ ì°¸ê³ 
- í˜¸ë‚¨ì§€ì—­ Best Case ë¶€ì¡±, ê²½ë¶/ê²½ë‚¨ ëŒ€ë¹„ ì—´ì„¸
- ë¶„ë‹¹ì œìƒ ë“± ì†Œê·œëª¨ ë³‘ì› Best Case ê°œë°œ í•„ìš”

**Follow-up**
- í˜¸ë‚¨ì§€ì—­ Best Case ë°œêµ´ ì „ëµ ìˆ˜ë¦½
- ë¶„ë‹¹ì œìƒ ë“± ì†Œí˜•ë³‘ì› ëŒ€ìƒ ëª¨ë¸ ì¼€ì´ìŠ¤ ê°œë°œ

**Comment**
- Small caseë„ Clinical ROIë¥¼ ì¦ëª…í•  ìˆ˜ ìˆëŠ” ì‚¬ë¡€ í•„ìš”

**DRI**
- Clinical Sales íŒ€ ë¦¬ë”
- Med Ed íŒ€ (Best Case ê°œë°œ ì‹œ ì—°ê³„)

---

## ğŸ“Œ Capital Sales
**Main Points**
- X phase-out â†’ Xi-R ê°€ê²© ì „ëµ ì¤‘ìš”
- 26~28ë…„ Greenfield ì¤‘ì‹¬ ë¦¬ì†ŒìŠ¤ ê³„íš í•„ìš”
- Tier2 ì¢…í•©ë³‘ì› ê¸°íšŒ ì¬íƒìƒ‰
- DRG-A ì§‘ì¤‘ ì •ì±…ì— ë”°ë¥¸ Surgical Flow ë³€í™” ë¶„ì„
- Training / Clinical / Service / Economic QTI ì „ë¬¸í™” í•„ìš”

**Follow-up**
- Xi-R ê°€ê²© ì „ëµì•ˆ ìˆ˜ë¦½
- Greenfield ì¤‘ì‹¬ ë¦¬ì†ŒìŠ¤ ë¡œë“œë§µ
- Tier2 GF ê¸°íšŒ ì¬ì •ì˜
- ì •ì±… ë³€í™”ì— ë”°ë¥¸ ë³‘ì› ë§¤í•‘

**Comment**
- ì •ì±… ë³€í™” ì£¼ëª©

**DRI**
- Capital íŒ€ ì „ëµ ë‹´ë‹¹
- ì •ì±…/ì‹œì¥ë¶„ì„ ë‹´ë‹¹ì

---

## ğŸ“Œ Customer Training
**Main Points**
- Credentialing â†’ Scoring ì‹œìŠ¤í…œ í•„ìš”
- SP Scoring ê¸€ë¡œë²Œ ì»¤ë®¤ë‹ˆì¼€ì´ì…˜
- ì™¸ê³¼ìˆ˜ìˆ ì—°êµ¬íšŒ/TR100 ì—°ê³„ ê´€ë¦¬
- dVCC/dVOC/dVAC ê°•í™”

**Follow-up**
- SP Scoring ê¸€ë¡œë²Œ ì»¤ë®¤ë‹ˆì¼€ì´ì…˜ ì°©ìˆ˜
- TR100 ë³‘ì›êµ° ê´€ë¦¬ ì²´ê³„ í™•ë¦½
- QTI ê¸°ë°˜ Training ë¦¬ë””ìì¸

**Comment**
- TR100 ìœ ì§€ ì „ëµì  ìì‚°

**DRI**
- Training íŒ€
- Global Training Ops

---

## ğŸ“Œ Product MKT
**Main Points**
- Capital ì „ëµ ì—°ê³„ í•„ìˆ˜
- Xi â†’ dV5 Trade ì „ëµ
- Revenue ì¤‘ì‹¬ ì „ëµ ìˆ˜ë¦½
- Greenfield vs Trade ë¦¬ì†ŒìŠ¤ ì „ëµ

**Follow-up**
- dV5 Trade ë³‘ì› ë§¤í•‘
- 26~28 Trade ìˆ˜ëŸ‰ ì—…ë°ì´íŠ¸

**Comment**
- ì „ëµì  Trade ì ‘ê·¼ í•„ìš”

**DRI**
- Product MKT íŒ€
- Capital Planning ë‹´ë‹¹

---

## ğŸ“Œ Digital Sales
**Main Points**
- 25/26: Expansion â†’ 26/28: Digital Hub/CI/Publications ê³„íš í•„ìš”

**Follow-up**
- 28ë…„ê¹Œì§€ íƒ€ì„ë¼ì¸ ìˆ˜ë¦½

**DRI**
- Digital Business Lead

---

## ğŸ“Œ RAQA
**Main Points**
- 11ì›” Resource Assumption
- Transvaginal í—ˆê°€ ìœ„í•œ Evidence í™•ë³´
- Ryan Shaw ë¯¸íŒ… â†’ 8ì›” í™•ì •

**Follow-up**
- í—ˆê°€ ì „ëµ/ìë£Œ ì¤€ë¹„
- ë¯¸íŒ… ì¼ì • ì¤€ë¹„

**DRI**
- RA Manager
- Clinical Evidence ë‹´ë‹¹

---

## ğŸ“Œ MKT
**Main Points**
- PRM ë°©í–¥ â†’ SSM/Ventral Hernia ê²€í† 
- Gastrectomy Surgeon ë¶„ì„

**Follow-up**
- ê¹€í˜•ì¼ êµìˆ˜ ì˜ˆì‚° ë°˜ì˜
- Surgeon ë¶„ì„ ë³´ê³ ì„œ ì‘ì„±

**DRI**
- MKT íŒ€
- Surgeon Intelligence ë‹´ë‹¹ì

---

## ğŸ“Œ Hospital MKT
**Main Points**
- ë³‘ì› ë‚´ë¶€ Voice ì „ëµ
- Society/Media ë…¸ì¶œ ì „ëµ

**Follow-up**
- Media ì „ëµ ê¸°íš

**DRI**
- Hospital MKT ë‹´ë‹¹ì

---

## ğŸ“Œ MACA
**Main Points**
- ì—°ë„ë³„ Executive/CHA ìˆ˜ ëª©í‘œ ì„¤ì •

**Follow-up**
- KOL ëª©í‘œ ìˆ˜ì¹˜í™” ë° Commercial alignment

**DRI**
- MACA Lead
- Commercial íŒ€

---

## ğŸ“Œ HEOR
**Main Points**
- Gastrectomy ê²½ì œì„± ë¶„ì„ ì¡°ê¸° ì§„í–‰
- MKT í™œìš© ë°©ì•ˆ êµ¬ì²´í™”
- Registry: Marcom

**Follow-up**
- Comparative study ì¼ì • ì¡°ì •
- HEOR â†’ MKT ì „ëµ ê³µìœ 

**DRI**
- HEOR ë¦¬ë”
- Marcom ë‹´ë‹¹

---

## ğŸ“Œ Customer Learning Team
**Follow-up**
- Q3: Semi Training ê³„íš (Chole/Colorectal/Gastrectomy)

**DRI**
- Customer Learning ë¦¬ë”

---

## ğŸ“Œ Service
**Main Points**
- ì—­ëŸ‰/ë‚´ë¶€ í˜‘ì—…/ì™¸ë¶€ ì»¤ë®¤ë‹ˆì¼€ì´ì…˜ êµ¬íší™”
- 26~28 ì¸¡ì • ê°€ëŠ¥í•œ ë¦¬ì†ŒìŠ¤ ê³„íš ìˆ˜ë¦½

**Follow-up**
- ëª©í‘œ ì •ë ¬ ì›Œí¬ìˆ ì¤€ë¹„

**DRI**
- Service íŒ€ ë¦¬ë”
- ê° ë¶€ì„œ ë¦¬ë”
